Advances in DNA and mRNA-Based Strategies for Cancer Immunotherapy: Part A
- 1st Edition, Volume 165 - May 1, 2025
- Imprint: Academic Press
- Editors: Arun Kumar Singh, Neeraj Mishra, Sumel Ashique, Pranav Kumar Prabhakar
- Language: English
- Hardback ISBN:9 7 8 - 0 - 4 4 3 - 3 4 4 9 5 - 4
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 3 4 4 9 6 - 1
Advances in DNA and mRNA-Based Strategies for Cancer Immunotherapy, Volume 165 in the Advances in Immunology series, presents current developments and comprehensive reviews in DN… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteAdvances in DNA and mRNA-Based Strategies for Cancer Immunotherapy, Volume 165 in the Advances in Immunology series, presents current developments and comprehensive reviews in DNA and mRNA vaccines: Significant therapeutic approach against cancer management, Nanoparticles for mRNA-based cancer immunotherapy, Nucleic acid Delivery as a therapeutic approach in cancer immunotherapy, Plasmid DNA and mRNA: Delivery approaches and challenges, Viral & Non-viral Delivery of mRNA against Cancer Cell, Progress in Modifying and Delivering mRNA therapies for Cancer Immunotherapy, and more.
Other chapters cover mRNA-Based Cancer Vaccines: A Novel Approach to Melanoma Treatment, Therapeutic mRNAs for cancer immunotherapy: from structure to delivery, Harnessing the immune system: Insights into cancer vaccines, Lipid Nanoparticle-Mediated mRNA Delivery in Cancer Immunotherapy, Immunotherapy Perspectives in the Era of B-Cell Editing in Cancer Treatment, Personalized Precision: Revolutionizing Cancer Treatment with mRNA-Based Vaccines in Melanoma Therapy, Revolutionizing Cancer Treatment: Exploring Novel Immunotherapeutics, Checkpoints, bispecifics, and Vaccines in Development, and more.
Other chapters cover mRNA-Based Cancer Vaccines: A Novel Approach to Melanoma Treatment, Therapeutic mRNAs for cancer immunotherapy: from structure to delivery, Harnessing the immune system: Insights into cancer vaccines, Lipid Nanoparticle-Mediated mRNA Delivery in Cancer Immunotherapy, Immunotherapy Perspectives in the Era of B-Cell Editing in Cancer Treatment, Personalized Precision: Revolutionizing Cancer Treatment with mRNA-Based Vaccines in Melanoma Therapy, Revolutionizing Cancer Treatment: Exploring Novel Immunotherapeutics, Checkpoints, bispecifics, and Vaccines in Development, and more.
- Presents current developments and comprehensive reviews in immunology
- Provides the latest in a longstanding and respected serial on the subject matter
- Focuses on recent advances in the field of immunology
Immunologists and infectious disease specialists, cell biologists and hematologists
1. DNA and mRNA vaccines: Significant therapeutic approach against cancer management.
2. Nanoparticles for mRNA-based cancer immunotherapy
3. Nucleic acid Delivery as a therapeutic approach in cancer immunotherapy
4. Plasmid DNA and mRNA: Delivery approaches and challenges
5. Viral & Non-viral Delivery of mRNA against Cancer Cell
6. Progress in Modifying and Delivering mRNA therapies for Cancer Immunotherapy
7. mRNA-Based Cancer Vaccines: A Novel Approach to Melanoma Treatment
8. Therapeutic mRNAs for cancer immunotherapy: from structure to delivery
9. Harnessing the immune system: Insights into cancer vaccines
10. Lipid Nanoparticle-Mediated mRNA Delivery in Cancer Immunotherapy
11. Immunotherapy Perspectives in the Era of B-Cell Editing in Cancer Treatment
12. Personalized Precision: Revolutionizing Cancer Treatment with mRNA-Based Vaccines in Melanoma Therapy
13. Revolutionizing Cancer Treatment: Exploring Novel Immunotherapeutics, Checkpoints, bispecifics, and Vaccines in Development
14. Recent progress, challenges (stability and in vivo distribution), and opportunities of DNA and mRNA Vaccine in cancer Immunotherapy
2. Nanoparticles for mRNA-based cancer immunotherapy
3. Nucleic acid Delivery as a therapeutic approach in cancer immunotherapy
4. Plasmid DNA and mRNA: Delivery approaches and challenges
5. Viral & Non-viral Delivery of mRNA against Cancer Cell
6. Progress in Modifying and Delivering mRNA therapies for Cancer Immunotherapy
7. mRNA-Based Cancer Vaccines: A Novel Approach to Melanoma Treatment
8. Therapeutic mRNAs for cancer immunotherapy: from structure to delivery
9. Harnessing the immune system: Insights into cancer vaccines
10. Lipid Nanoparticle-Mediated mRNA Delivery in Cancer Immunotherapy
11. Immunotherapy Perspectives in the Era of B-Cell Editing in Cancer Treatment
12. Personalized Precision: Revolutionizing Cancer Treatment with mRNA-Based Vaccines in Melanoma Therapy
13. Revolutionizing Cancer Treatment: Exploring Novel Immunotherapeutics, Checkpoints, bispecifics, and Vaccines in Development
14. Recent progress, challenges (stability and in vivo distribution), and opportunities of DNA and mRNA Vaccine in cancer Immunotherapy
- Edition: 1
- Volume: 165
- Published: May 1, 2025
- Imprint: Academic Press
- No. of pages: 198
- Language: English
- Hardback ISBN: 9780443344954
- eBook ISBN: 9780443344961
AS
Arun Kumar Singh
Arun Kumar Singh earned his M. Pharm in Pharmaceutics from Galgotias University and currently serves as an Assistant Professor at the Amity Institute of Pharmacy, Amity University, Greater Noida. With over a decade of experience teaching pharmacology-related courses, Professor Singh has cultivated a diverse range of research interests, including nano-formulation, blockchain, IoT, machine learning, cancer, artificial intelligence, big data, and neuroscience. He has authored 5 book chapters, edited multiple books with notable international publishers, and has published 24 review papers, including two in the prestigious Biochimica et Biophysica Acta (BBA) – Reviews on Cancer. Renowned for his research acumen, innovative thinking, leadership, and positive outlook, Professor Singh's dedication and hard work have distinguished him as a leading figure in his field.
Affiliations and expertise
Assistant Professor, Amity Institute of Pharmacy, IndiaNM
Neeraj Mishra
Dr. Neeraj Mishra is a Professor and Head of the Department of Pharmaceutics at Amity Institute of Pharmacy, India, a position he has held since July 2019. With nearly two decades of teaching and research experience, Dr. Mishra has authored over 100 publications on novel drug delivery systems, focusing on nanocarriers and microparticles for treating breast and colon cancer, as well as neurodegenerative disorders. He has written several books and book chapters, and holds three international and two Indian patents. Dr. Mishra has received numerous accolades, including the "Distinguished Professor Award" (2019, 2021) and the "Outstanding Scientist Award" (2020). He has served as a guest editor for Bentham Sciences and is recognized in Stanford University's World Scientists Rankings for 2022 and 2024.
Affiliations and expertise
Professor and Head of Department, Amity Institute of Pharmacy, Amity University, IndiaSA
Sumel Ashique
Sumel Ashique has been working as an assistant professor at Bengal College of Pharmaceutical Sciences & Research, Durgapur 713212, West Bengal, India, West Bengal, India. He has 3.5 years of teaching experience. He has achieved 70+ publications of International and national accredited reputed journals (Scopus, UGC). He has knowledge in drug delivery, nanotechnology and targeted treatment strategy. He has also 6 granted patents from IP and Australia & 20 book chapters have been submitted to well-known publishers like Springer, Elsevier, Bentham and Taylor & Francis. Currently he is editing 13 books under CRC Press, Taylor & Francis, Springer and Wiley.
Affiliations and expertise
Asst. Professor, Department of Pharmaceutical Technology, Bharat Technology, Uluberia, West Bengal, IndiaPP
Pranav Kumar Prabhakar
Dr. Pranav Kumar Prabhakar is currently working as a Professor in the Department of Biotechnology at Nagaland University, Kohima, Nagaland, India. He has been listed among the World’s Top 2% Scientists (as published by Stanford University, USA, in 2021, 2022, 2023, and 2024). He earned his PhD in Biotechnology from IIT Madras. His primary research interests include elucidating molecular mechanisms and strategies for oral insulin delivery and mimicking signaling pathways in metabolic disorders (diabetes) using natural products. He is a member of the Royal Society of Chemistry and the Asia-Pacific Chemical, Biological & Environmental Engineering Society. He also serves as an editorial board member and reviewer for several reputed national and international journals. Dr. Pranav has received various honors, including a travel grant to attend ATTD 2009 in Greece, sponsored by the Indian Institute of Technology Madras and the Council for Scientific and Industrial Research (CSIR), and approved by the Department of Science and Technology (DST). He has published over 115 research articles in journals, authored or edited 17 books, contributed more than 40 book chapters, and delivered 9 oral and poster presentations at scientific meetings.
Affiliations and expertise
Department of Biotechnology, School of Engineering and Technology, Nagaland University, Meriema, Kohima, Nagaland-797004, India